Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Other Non-Current Liabilities (2019 - 2024)

Lipocine's Other Non-Current Liabilities history spans 7 years, with the latest figure at $3586.0 for Q3 2024.

  • For Q3 2024, Other Non-Current Liabilities fell 87.82% year-over-year to $3586.0; the TTM value through Sep 2024 reached $3586.0, down 87.82%, while the annual FY2023 figure was $17166.0, 92.53% down from the prior year.
  • Other Non-Current Liabilities reached $3586.0 in Q3 2024 per LPCN's latest filing, down from $141668.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $37.8 million in Q2 2022 to a low of $3586.0 in Q3 2024.
  • Average Other Non-Current Liabilities over 5 years is $6.3 million, with a median of $264099.0 recorded in 2022.
  • Peak YoY movement for Other Non-Current Liabilities: soared 3255.02% in 2022, then tumbled 99.72% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $20.0 million in 2020, then crashed by 96.02% to $795796.0 in 2021, then plummeted by 71.12% to $229856.0 in 2022, then tumbled by 92.53% to $17166.0 in 2023, then plummeted by 79.11% to $3586.0 in 2024.
  • Per Business Quant, the three most recent readings for LPCN's Other Non-Current Liabilities are $3586.0 (Q3 2024), $141668.0 (Q2 2024), and $57238.0 (Q1 2024).